Gene Delivery in Bone Tissue Engineering: Progress and Prospects Using Viral and Nonviral Strategies

Tissue Engineering

Volumn 10, Issue 1-2, 2004, Pages 295-307

  Partridge, Kris A ^a,b   Oreffo, Richard O C ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BIOMATERIAL; CHITOSAN; PLASMID VECTOR; RETROVIRUS VECTOR;

AGING; ANALYTIC METHOD; BACULOVIRUS; BONE REGENERATION; BONE TISSUE; CARTILAGE; GENE DELIVERY SYSTEM; GENE TRANSFER; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; MESENCHYME; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; SAFETY; TECHNIQUE; TISSUE ENGINEERING; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; BONE REGENERATION; BONE SUBSTITUTES; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; OSTEOBLASTS; PLASMIDS; RETROVIRIDAE; TISSUE ENGINEERING; TRANSDUCTION, GENETIC;

EID: 1042289608     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/107632704322791934     Document Type: Review

References (81)

1. Rose, F.R., and Oreffo, R.O.C. Bone tissue engineering: Hope vs hype. Biochem. Biophys. Res. Commun. 292, 1, 2002.
2. Doll, B., Sfeir, C., Winn, S., Huard, J., and Hollinger, J. Critical aspects of tissue-engineered therapy for bone regeneration. Crit. Rev. Eukaryot. Gene Exp. 11, 173, 2001.
3. Oreffo, R.O.C., and Triffitt, J.T. Future potentials for using osteogenic stem cells and biomaterials in orthopedics. Bone 25, 5S, 1999.
4. Filshie, R.J., Zannettino, A.C., Makrynikola, V., Gronthos, S., Henniker, A.J., Bendall, L.J., Gottlieb, D.J., Simmons, P.J., and Bradstock, K.F. MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignancies. Leukemia 12, 414, 1998.
5. Fermor, B., Gundle, R., Evans, M., Emerton, M., Pocock, A., and Murray D. Primary human ostioblast proliferation and prostaglandin E2 release in response to mechanical strain in vitro. Bone 22, 637, 1998.
6. Bianco, P., and Robey, P.G. Stem cells in tissue engineering. Nature 414, 118, 2001.
7. Friedenstein, A.J., Piatetzky-Shapiro, I.I., and Petrakova, K.V. Osteogenesis in transplants of bone marrow cells. J. Embryol. Exp. Morphol. 16, 381, 1966.
8. Bruder, S.P., Horowitz, M.C., Mosca, J.D., and Haynesworth, S.E. Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone 21, 225, 1997.
9. Simmons, P.J., and Torok-Storb, B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78, 55, 1991.
10. Haynesworth, S.E., Baber, M.A., and Caplan, A.I. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13, 69, 1992.
11. Joyner, C.J., Bennett, A., and Triffitt, J.T. Identification and enrichment of human osteoprogenitor cells by using differentiation stage-specific monoclonal antibodies. Bone 21, 1, 1997.
12. + fraction of adult human bone marrow contains the osteogenic precursors. Blood 84, 4164, 1994.
13. Howard, D., Partridge, K., Yang, X., Clarke, N.M.P., Okubo, Y., Bessho, K., Howdle, S.M., Shakesheff, K.M., and Oreffo, R.O. Immunoselection and adenoviral genetic modulation of human osteoprogenitors: In vivo bone formation on PLA scaffold. Biochem. Biophys. Res. Commun. 299, 208, 2002.
14. Bruder, S.P., Ricalton, N.S., Boynton, R.E., Connolly, T.J., Jaiswal, N., Zaia, J., and Barry, F.P. Mesenchymal stem cell surface antigen SB-10 corresponds to activated leukocyte cell adhesion molecule and is involved in osteogenic differentiation. J. Bone Miner. Res. 13, 655, 1998.
15. Barry, F.P., Boynton, R.E., Haynesworth, S., Murphy, J.M., and Zaia, J. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem. Biophys. Res. Commun. 265, 134, 1999.
16. Triffitt, J.T. Osteogenic stem cells and orthopedic engineering: Summary and update. J. Biomed. Mater. Res. 63, 384, 2002.
17. Ashton, B.A., Allen, T.D., Howlett, C.R., Eaglesom, C.C., Hattori, A., and Owen, M. Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin. Orthop. Relat. Res. 151, 294, 1980.
18. Ohgushi, H., Goldberg, V.M., and Caplan, A.I. Repair of bone defects with marrow cells and porous ceramic. Experiments in rats. Acta Orthop. Scand. 60, 334, 1989.
19. Horwitz, E.M., Prockop, D.J., Fitzpatrick, L.A., Koo, W.W., Gordon, P.L., Neel, M., Sussman, M., Orchard, P., Marx, J.C., Pyeritz, R.E., and Brenner, M.K. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 5, 309, 1999.
20. Urist, M.R. Bone: Formation by autoinduction. Science 150, 893, 1965.
21. Wozney, J.M., and Rosen, V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin. Orthop. 346, 26, 1998.
22. Li, R.H., and Wozney, J.M. Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol. 19, 255, 2001.
23. Kirker-Head, C.A. Potential applications and delivery strategies for bone morphogenetic proteins. Adv. Drug Deliv. Rev. 43, 65, 2000.
24. Yamaguchi, A., Komori, T., and Suda, T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr. Rev. 21, 393, 2000.
25. Govender, S., Csimma, C., Genant, H.K., Valentin-Opran, A., Amit, Y., Arbel, R., Aro, H., Atar, D., Bishay, M., Borner, M.G., Chiron, P., Choong, P., Cinats, J., Courtenay, B., Feibel, R., Geulette, B., Gravel, C., Haas, N., Raschke, M., Hammacher, E., van, d., V, Hardy, P., Holt, M., Josten, C., Ketterl, R.L., Lindeque, B., Lob, G., Mathevon, H., McCoy, G., Marsh, D., Miller, R., Munting, E., Oevre, S., Nordsletten, L., Patel, A., Pohl, A., Rennie, W., Reynders, P., Rommens, P.M., Rondia, J., Rossouw, W.C., Daneel, P.J., Ruff, S., Ruter, A., Santavirta, S., Schildhauer, T.A., Gekle, C., Schnettler, R., Segal, D., Seiler, H., Snowdowne, R.B., Stapert, J., Taglang, G., Verdonk, R., Vogels, L., Weckbach, A., Wentzensen, A., and Wisniewski, T. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg. Am. 84, 2123, 2002.
26. Zhang, X.-Y., La Russa, V.F., Bao, L., Kolls, J., Schwarzenberger, P., and Reiser, J. Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells. Mol. Ther. 5, 555, 2002.
27. Oreffo, R.O.C., Virdi, A.S., and Triffitt, J.T. Retroviral marking of human bone marrow fibroblasts: In vitro expansion and localization in calvarial sites after subcutaneous transplantation in vivo. J. Cell. Physiol. 186, 201, 2001.
28. Laurencin, D.T., Attawia, M.A., Lu, L.Q., Borden, M.D., Lu, H.H., Gorum, W.J., and Leopold, P.L. Poly(lactide-co-glycolide)/hydroxyapatite delivery of BMP-2-producing cells: A regional gene therapy approach to bone regeneration. Biomaterials 22, 1271, 2001.
29. Breitbart, A.S., Grande, D.A., Mason, J.M., Barcia, M., James, T., and Grant, R.T. Gene-enhanced tissue engineering: Applications of bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene. Ann. Plast. Surg. 42, 488, 1999.
30. Li, Z., Düllman, J., Schiedlmeier, B., Schmidt, M., von Kalle, C., Meyer, J., Forster, M., Stocking, C., Wahlers, A., Frank, O., Ostertag, W., Kühlcke, K., Eckert, H.-G., Fehse, B., and Baum, C. Murine leukemia induced by retroviral gene marking. Science 296, 497, 2002.
31. Kochanek, S., Clemens, P.R., Mitani, K., Chen, H.-H., Chan, S., and Caskey, C.T. A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc. Natl. Acad. Sci. U.S.A. 93, 5731, 1996.
32. Soifer, H., Higo, C., Logg, C.R., Jih, L.J.-L., Shichinohe, T., Harboe-Schmidt, E., Mitani, K., and Kasahara, N. A novel, helper-dependent, adenovirus-retrovirus hybrid vector: Stable transduction by a two-stage mechanism. Mol. Ther. 5, 599, 2002.
33. Barnett, B.G., Crews, C.J., and Douglas, J.T. Targeted adenoviral vectors. Biochim. Biophys. Acta 1575, 1, 2002.
34. Molin, M., Shoshan, M.C., Ohman-Forslund, K., Linder, S., and Akuta, T. Two novel adenovirus vector systems permitting regulated protein expression in gene transfer experiments. J. Virol. 72, 8358, 1998.
35. Wettergreen, M.A., Hunniford, J.W., Crawford, J.M., and Adami, G.R. An adenoviral system for tetracycline-regulated TGF-β expression mediates a reversible cell cycle arrest. Eur. J. Oral Sci. 109, 415, 2001.
36. Anton, M., and Graham, F.L. Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein: A molecular switch for control of gene expression. J. Virol. 69, 4600, 1995.
37. Sato, Y., Tanaka, K., Lee, G., Kanegae, Y., Sakai, Y., Kaneko, S., Nakabayashi, H., Tamaoki, T., and Saito, I. Enhanced and specific gene expression via tissue-specific production of Cre recombinase using adenovirus vector. Biochem. Biophys. Res. Commun. 244, 455, 1998.
38. Marshall, E. Gene therapy death prompts review of adenovirus vector. Science 286, 2244, 1999.
39. Musgrave, D.S., Bosche, P., Ghivizzani, S., Robbins, P.D., Evans, C.H., and Huard, J. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone 24, 541, 1999.
40. Okubo, Y., Bessho, K., Fujimura, K., Iizuka, T., and Miyatake, S.-I. In vitro and in vivo studies of a bone morphogenetic protein-2 expressing adenoviral vector. J. Bone Joint Surg. 83(Suppl. 1), S1, 2001.
41. Baltzer, A.W.A., Latterman, C., Whalen, J.D., Wooley, P., Weiss, K., Grimm, M., Ghivizzani, S., Robbins, P.D., and Evans, C.H. Genetic enhancement of fracture repair: Healing of an experimental segmental defect by adenoviral transfer of the BMP2 gene. Gene Ther. 7, 734, 2000.
42. Lieberman, J.R., Le, L.Q., Wu, L., Finerman, G.A.M., Berk, A., Witte, O.N., and Stevenson, S. Regional gene therapy with a BMP-2 producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J. Orthop. Res. 16, 330, 1998.
43. Lieberman, J.R., Daluiski, A., Stevenson, S., Wu, L., McAllister, P., Lee, Y.P., Kabo, M., Finerman, G.A.M., Berk, A., and Witte, O.N. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J. Bone Joint Surg. Am. 81, 905, 1999.
44. Abe, N., Lee, Y., Sato, M., Zhang, X., Wu, J., Mitani, K., and Lieberman, J. Enhancement of bone repair with a helper-dependent adenoviral transfer of bone morphogenetic protein-2. Biochem. Biophys. Res. Commun. 297, 523, 2002.
45. Partridge K., Yang, X., Clarke, N.M., Okubo, Y., Bessho, K., Sebald, W., Howdle, S.M., Shakesheff, K.M., and Oreffo, R.O. Adenoviral BMP-2 gene transfer in mesenchymal stem cells: In vitro and in vivo bone formation on biodegradable polymer scaffolds. Biochem. Biophys. Res. Commun. 292, 144, 2002.
46. Olmsted, E.A., Blum, J.S., Rill, D., Yotnda, P., Gugala, Z., Lindsey, R.W., and Davis, A.R. Adenovirus-mediated BMP2 expression in human bone marrow stromal cells. J. Cell. Biochem. 82, 11, 2001.
47. Lee, J.Y., Peng, H., Usas, A., Musgrave, D.S., Cummins, J., Pelinkovic, D., Jankowski, R., Ziran, B., Robbins, P.D., and Huard, J. Enhancement of bone healing based on ex vivo gene therapy using human muscle derived cells expressing bone morphogenetic protein 2. Hum. Gene Ther. 13, 1201, 2002.
48. Musgrave, D.S., Pruchnic, R., Wright, V., Bosch, P., Ghivizzani, S., Robbins, P.D., and Huard, J. The effect of bone morphogenetic protein-2 expression on the early fate of skeletal muscle-derived cells. Bone 28, 499, 2001.
49. Donsante, A., Vogler, C., Muzyczka, N., Crawford, J.M., Barker, J., Flotte, T., Campbell-Thompson, M., Daly, T., and Sands, M.S. Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors. Gene Ther. 8, 1343, 2001.
50. Kost, T.A., and Condreay, J.P. Recombinant baculoviruses as mammalian cell gene-delivery vectors. Trends Biotechnol. 20, 173, 2002.
51. Condreay, J.P., Witherspoon, S.M., Clay, W.C., and Kost, T.A. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc. Natl. Acad. Sci. U.S.A. 96, 127, 1999.
52. Monaci, P., Urbanelli, L., and Fontana, L. Phage as gene delivery vectors. Curr. Opin. Mol. Ther. 3, 159, 2001.
53. Nakanishi, M., Eguchi, A., Akuta, T., Nagoshi, E., Fujita, S., Okabe, J., Senda, T., and Hasegawa, M. Basic peptides as functional components of non-viral gene transfer vehicles. Curr. Peptide Peptide Sci. 4, 141, 2003.
54. Kumar, V.V., Singh, R.S., and Chaudhuri, A. Cationic transfection lipids in gene therapy: Successes, setbacks, challanges and promises. Curr. Med. Chem. 10, 995, 2003.
55. Pouton, C.W. and Seymour, L.W. Key issues in non-viral gene delivery. Adv. Drug Deliv. Rev. 34, 3, 1998.
56. Garnett, M.C. Gene-delivery systems using cationic polymers. Crit. Rev. Ther. Drug Carrier Syst. 16, 147, 1999.
57. Deng, G.M., Nilsson, I.M., Verdrengh, M., Collins, L.V., and Tarkowski, A. Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat. Med. 5, 702, 1999.
58. Loisel, S., Le Gall, C., Doucet, L., Feree, C., and Floch, V. Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes. Hum. Gene Ther. 12, 685, 2001.
59. Tachibana, R., Harashima, H., Shinohara, Y., and Kiwada, H. Quantitative studies on the nuclear transport of plasmid DNA and gene expression employing nonviral vectors. Adv. Drug Deliv. Rev. 52, 219, 2001.
60. Towler, D.A. and St. Arnaud, R. Use of cultured osteoblastic cells to identify and characterize transcriptional regulatory complexes. In: Bilezikian, J.P., Raisz, L.G., and Rodan, G.A., eds. Principles of Bone Biology, 2nd ed. San Diego, CA: Academic Press, 2002, p. 1503.
61. Liu, F., Qi, H., Huang, L., and Liu, D. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Ther. 4, 517, 1997.
62. de Lima, M.C.P., Neves, S., Filipe, A., Duzgunes, N., and Simoes, S. Cationic liposomes for gene delivery: From biophysics to biological applications. Curr. Med. Chem. 10, 919, 2003.
63. Alton, E.W.F.W., Geddes, D.M., Gill, D.R., Higgins, C.F., Hyde, S.C., Innes, J.A., and Porteous, D.J. Towards gene therepy for cystic fibrosis: A clinical progress report. Gene Ther. 5, 291, 1998.
64. Griesenbach, U., Ferrari, S., Geddes, D.M., and Alton, E.W.F.W. Gene therapy progress and prospects: Cystic fibrosis. Gene Ther. 9, 1344, 2002.
65. Hirao, K., Sugita, T., Kubo, T., Igarashi, K., Tanimoto, K., Murakami, T., Yasunaga, Y., and Ochi, M. Targeted gene delivery to human osteosarcoma cells with magnetic cationic liposomes under a magnetic field. Int. J. Oncol. 22, 1065, 2003.
66. Richardson, S.C.W., Kolbe, H.V.J., and Duncan, R. Potential of low molecular mass chitosan as a DNA delivery system: Biocompatibility, body distribution and ability to complex and protect DNA. Int. J. Pharm. 178, 231, 1999.
67. Suh, J.K., and Matthew, H.W. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: A review. Biomaterials 21, 2589, 2000.
68. Ishii, T., Okahata, Y., and Sato, T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim. Biophys. Acta 1514, 51, 2001.
69. Mao, H.Q., Roy, K., Troung-Le, V.L., Janes, K.A., Lin, K.Y., Wang, Y., August, J.T., and Leong, K.W. Chitosan-DNA nanoparticles as gene carriers: Synthesis, characterization and transfection efficiency. J. Control. Release 70, 399, 2001.
70. Corsi, K., Chellat, F., Yahia, L., and Fernandes, J.C. Mesenchymal stem cell, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials 24, 1255, 2003.
71. Hashida, M., Mahato, R.I., Kawabata, K., Miyao, T., Nihikawa, M., and Takahara, Y. Pharmacokinetics and targeted delivery of proteins and genes. J. Control. Release 41, 97, 1996.
72. Meuli, M., Liu, Y., Liggitt, D., Kashani-Sabet, M., Knauer, S., Meuli-Simmen, C., Harrison, M.R., Adzick, N.S., Heath, T.D., and Debs, R.J. Efficient gene expression in skin wound sites following local plasmid injection. J. Invest. Dermatol. 116, 131, 2001.
73. Dean, D.A. Import of plasmid DNA into the nucleaus is sequence specific. Exp. Cell Res. 230, 293, 1997.
74. Zanta, M.A., Belguise-Valladier, P., and Behr, J.-P. Gene delivery: A single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. U.S.A. 96, 91, 1999.
75. Branden, L.J., Mohamed, A.J., and Smith, C.I.E. A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA. Nat. Biotechnol. 17, 784, 1999.
76. Pasquini, S., Deng, H., Reddy, S.T., Giles-Davis, W., and Ertl, H.C.J. The effect of CpG sequences on the B cell response to a viral glycoprotein encoded by a plasmid vector. Gene Ther. 6, 1448, 1999.
77. Bonadio, J., Smiley, E., Patil, P., and Goldstein, S.A. Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration. Nat. Med. 5, 753, 1999.
78. Jaroszeski, M.J., Gilbert, R., Nicolau, C., and Heller, R. In vivo gene delivery by electroporation. Adv. Drug Deliv. Rev. 35, 131, 1999.
79. Brunner, S., Furtbauer, E., Sauer, T., Kursa, M., and Wagner, E. Overcoming the nuclear barrier: Cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation. Mol. Ther. 5, 80, 2002.
80. Mussauer, H., Sukhorukov, V.L., and Zimmermann, U. Trehalose improves survival of electrotransfected mammalian cells. Cytometry 45, 161, 2001.
81. Davidson, J.M., Krieg, T., and Eming, S.A. Particle-mediated gene therapy of wounds. Wound Rep. Regen. 8, 452, 2000.